PRESENTATION AT TCT/ACC 2015
San Francisco California

E-mail sent by TCT/ACC 2015 organizers
Having presented the results of the first human patient treated with the innovative procedure of Dr. Jose E. Herrera and colleagues in the TCT / ACC 2014 Congress, the event organizers TCT / ACC invited Dr. Herrera to participate as Faculty at the 2015 conference in San Francisco, California.

Lecture Schedule
Additionally, he performed a lecture in which shows the results of the 6 patients already treated with this innovative alternative for heart failure treatment.
Lecture:
Percutaneous Transluminal Caval flow Restriction with Caval Counterpulsation Balloon in Ischemic and Nonischemic Heart Failure Patients
He also was interviewed for Telemundo, moments before the start of the TCT / ACC 2015 event.
Watch the Interview
E-mail sent by TCT/ACC 2015 organizers |
Having presented the results of the first human patient treated with the innovative procedure of Dr. Jose E. Herrera and colleagues in the TCT / ACC 2014 Congress, the event organizers TCT / ACC invited Dr. Herrera to participate as Faculty at the 2015 conference in San Francisco, California.
Lecture Schedule |
Lecture:
Percutaneous Transluminal Caval flow Restriction with Caval Counterpulsation Balloon in Ischemic and Nonischemic Heart Failure Patients
He also was interviewed for Telemundo, moments before the start of the TCT / ACC 2015 event.
Watch the Interview
Watch the Interview
No comments:
Post a Comment